{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:00:45Z","timestamp":1773054045432,"version":"3.50.1"},"reference-count":138,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Liver transplantation is known to generate significant inflammation in the entire organ based on the metabolic profile and the tissue\u2019s ability to recover from the ischemia-reperfusion injury (IRI). This cascade contributes to post-transplant complications, affecting both the synthetic liver function (immediate) and the scar development in the biliary tree. The new occurrence of biliary strictures, and the recurrence of malignant and benign liver diseases, such as cholangiocarcinoma (CCA) and primary sclerosing cholangitis (PSC), are direct consequences linked to this inflammation. The accumulation of toxic metabolites, such as succinate, causes undirected electron flows, triggering the releases of reactive oxygen species (ROS) from a severely dysfunctional mitochondrial complex 1. This initiates the inflammatory IRI cascade, with subsequent ischemic biliary stricturing, and the upregulation of pro-tumorigenic signaling. Such inflammation is both local and systemic, promoting an immunocompromised status that can lead to the recurrence of underlying liver disease, both malignant and benign in nature. The traditional treatment for CCA was resection, when possible, followed by cytotoxic chemotherapy. Liver transplant oncology is increasingly recognized as a potentially curative approach for patients with intrahepatic (iCCA) and perihilar (pCCA) cholangiocarcinoma. The link between IRI and disease recurrence is increasingly recognized in transplant oncology for hepatocellular carcinoma. However, smaller numbers have prevented similar analyses for CCA. The mechanistic link may be even more critical in this disease, as IRI causes the most profound damage to the intrahepatic bile ducts. This article reviews the underlying mechanisms associated with biliary inflammation and biliary pathology after liver transplantation. One main focus is on the link between transplant-related IRI-associated inflammation and the recurrence of cholangiocarcinoma and benign liver diseases of the biliary tree. Risk factors and protective strategies are highlighted.<\/jats:p>","DOI":"10.3390\/cancers16162789","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T07:01:25Z","timestamp":1723100485000},"page":"2789","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9275-4744","authenticated-orcid":false,"given":"Chase J.","family":"Wehrle","sequence":"first","affiliation":[{"name":"Transplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2708-1261","authenticated-orcid":false,"given":"Rebecca","family":"Panconesi","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Satish","sequence":"additional","affiliation":[{"name":"Transplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA"},{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7589-4489","authenticated-orcid":false,"given":"Marianna","family":"Maspero","sequence":"additional","affiliation":[{"name":"General Surgery and Liver Transplantation Unit, IRCCS Istituto Tumori, 20133 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9566-8243","authenticated-orcid":false,"given":"Chunbao","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Karakaya","sequence":"additional","affiliation":[{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erlind","family":"Allkushi","sequence":"additional","affiliation":[{"name":"Transplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9429-5465","authenticated-orcid":false,"given":"Jamak","family":"Modaresi Esfeh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Transplant Hepatology, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Whitsett Linganna","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Transplant Hepatology, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-4034","authenticated-orcid":false,"given":"Wen Wee","family":"Ma","sequence":"additional","affiliation":[{"name":"Novel Therapeutics Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-0081","authenticated-orcid":false,"given":"Masato","family":"Fujiki","sequence":"additional","affiliation":[{"name":"Transplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Transplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Miller","sequence":"additional","affiliation":[{"name":"Transplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C. H.","family":"Kwon","sequence":"additional","affiliation":[{"name":"Transplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Aucejo","sequence":"additional","affiliation":[{"name":"Transplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Schlegel","sequence":"additional","affiliation":[{"name":"Transplantation Center, Cleveland Clinic, Cleveland, OH 44195, USA"},{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.3748\/wjg.v28.i40.5807","article-title":"Improving the prognosis before and after liver transplantation: Is muscle a game changer?","volume":"28","author":"Goffaux","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jamainternmed.2021.2051","article-title":"Factors Associated with Access to and Receipt of Liver Transplantation in Veterans with End-stage Liver Disease","volume":"181","author":"Kanwal","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.2007.50","article-title":"Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas","volume":"299","author":"Axelrod","year":"2008","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2008.720","article-title":"Disparities in liver transplantation before and after introduction of the MELD score","volume":"300","author":"Moylan","year":"2008","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11901-020-00527-9","article-title":"Selection for Liver Transplantation: Indications and Evaluation","volume":"19","author":"Mahmud","year":"2020","journal-title":"Curr. Hepatol. Rep."},{"key":"ref_7","unstructured":"Surveillance, Epidemiology, and End Results (2023). Cancer Stat Facts: Liver and Intrahepatic Bile Duct Cancer, NCIS."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1755738016653419","article-title":"Primary and secondary liver tumours","volume":"9","author":"Watson","year":"2016","journal-title":"InnovAiT"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.20739","article-title":"Ischemia\/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model","volume":"42","author":"Kranenburg","year":"2005","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/lt.21193","article-title":"Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways","volume":"13","author":"Man","year":"2007","journal-title":"Liver Transpl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/bjs.5382","article-title":"Selective portal clamping to minimize hepatic ischaemia-reperfusion damage and avoid accelerated outgrowth of experimental colorectal liver metastases","volume":"93","author":"Kranenburg","year":"2006","journal-title":"Br. J. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/transplantology2020015","article-title":"Mitochondrial Reprogramming\u2014What Is the Benefit of Hypothermic Oxygenated Perfusion in Liver Transplantation?","volume":"2","author":"Panconesi","year":"2021","journal-title":"Transplantology"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Parente, A., Cho, H.D., Kim, K.H., and Schlegel, A. (2023). Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076224"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Qureshi, A.A., Wehrle, C.J., Ferreira-Gonzalez, S., Jiao, C., Hong, H., Dadgar, N., Arpi-Palacios, J., Phong, Y.P., Kim, J., and Sun, K. (JHEP Rep., 2024). Tumor Organoids for Primary Liver Cancers: A Systematic Review of Current Applications in Diagnostics, Disease Modeling, and Drug Screening, JHEP Rep., in press.","DOI":"10.1016\/j.jhepr.2024.101164"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00007890-199105000-00013","article-title":"Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution","volume":"51","author":"Furukawa","year":"1991","journal-title":"Transplantation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archsurg.2011.240","article-title":"Liver transplantation using organ donation after cardiac death: A clinical predictive index for graft failure-free survival","volume":"146","author":"Hong","year":"2011","journal-title":"Arch. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MOT.0000000000000963","article-title":"Liver perfusion strategies: What is best and do ischemia times still matter?","volume":"27","author":"Panconesi","year":"2022","journal-title":"Curr. Opin. Organ Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/lt.25287","article-title":"Onset of Donor Warm Ischemia Time in Donation after Circulatory Death Liver Transplantation: Hypotension or Hypoxia?","volume":"24","author":"Kalisvaart","year":"2018","journal-title":"Liver Transpl."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","article-title":"Ischemia-reperfusion injury: Molecular mechanisms and therapeutic targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41419-021-03878-3","article-title":"Resolving the graft ischemia-reperfusion injury during liver transplantation at the single cell resolution","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2021.02.011","article-title":"Bile formation and secretion: An update","volume":"75","author":"Boyer","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/lt.21361","article-title":"Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors","volume":"14","author":"Chan","year":"2008","journal-title":"Liver Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2022.01.024","article-title":"Protective mechanisms and current clinical evidence of hypothermic oxygenated machine perfusion (HOPE) in preventing post-transplant cholangiopathy","volume":"76","author":"Schlegel","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/SLA.0b013e3181d3d3da","article-title":"The increased costs of donation after cardiac death liver transplantation: Caveat emptor","volume":"251","author":"Jay","year":"2010","journal-title":"Ann. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/lt.21166","article-title":"Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation","volume":"13","author":"Buis","year":"2007","journal-title":"Liver Transpl."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/TP.0000000000003928","article-title":"Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes from a Multicenter Cohort","volume":"106","author":"Croome","year":"2022","journal-title":"Transplantation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1097\/TP.0000000000004528","article-title":"Biliary Complications After Liver Transplantation in the United States: Changing Trends and Economic Implications","volume":"107","author":"Manay","year":"2023","journal-title":"Transplantation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/SLA.0000000000002419","article-title":"Comparison of Postoperative Outcomes between Donation after Circulatory Death and Donation after Brain Death Liver Transplantation Using the Comprehensive Complication Index","volume":"266","author":"Kalisvaart","year":"2017","journal-title":"Ann. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1432-2277.2012.01508.x","article-title":"Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors","volume":"25","author":"Taner","year":"2012","journal-title":"Transpl. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e1277","DOI":"10.1097\/TXD.0000000000001277","article-title":"Ischemic Cholangiopathy Postdonation after Circulatory Death Liver Transplantation: Donor Hepatectomy Time Matters","volume":"8","author":"Goussous","year":"2022","journal-title":"Transplant. Direct"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/ajt.15241","article-title":"In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival","volume":"19","author":"Watson","year":"2019","journal-title":"Am. J. Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2017.08.028","article-title":"Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans","volume":"68","author":"Kron","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Azad, A.I., Rosen, C.B., Taner, T., Heimbach, J.K., and Gores, G.J. (2020). Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation. Cancers, 12.","DOI":"10.3390\/cancers12113157"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2019.04.023","article-title":"Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study","volume":"242","author":"Wong","year":"2019","journal-title":"J. Surg. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bpg.2017.04.004","article-title":"Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation","volume":"31","author":"Visseren","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Babboni, S., Vacca, P.G., Simonini, L., Pezzati, D., Martinelli, C., Frongillo, F., Bianco, G., Marciano, E., Basta, G., and Ghinolfi, D. (2024). Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies. J. Clin. Med., 13.","DOI":"10.3390\/jcm13061804"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature13909","article-title":"Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS","volume":"515","author":"Chouchani","year":"2014","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Schlegel, A., Muller, X., Mueller, M., Stepanova, A., Kron, P., de Rougemont, O., Muiesan, P., Clavien, P.A., Galkin, A., and Meierhofer, D. (2020). Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation. eBioMedicine, 60.","DOI":"10.1016\/j.ebiom.2020.103014"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00007890-199309000-00001","article-title":"The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation","volume":"56","author":"Noack","year":"1993","journal-title":"Transplantation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/hep.32166","article-title":"Persistent biliary hypoxia and lack of regeneration are key mechanisms in the pathogenesis of posttransplant nonanastomotic strictures","volume":"75","author":"Overi","year":"2022","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nm.3212","article-title":"Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I","volume":"19","author":"Chouchani","year":"2013","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Eden, J., Breuer, E., Birrer, D., M\u00fcller, M., Pfister, M., Mayr, H., Sun, K., Widmer, J., Huwyler, F., and Ungeth\u00fcm, U. (2023). Screening for mitochondrial function before use-routine liver assessment during hypothermic oxygenated perfusion impacts liver utilization. eBioMedicine, 98.","DOI":"10.1016\/j.ebiom.2023.104857"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/STROKEAHA.117.019687","article-title":"Critical Role of Flavin and Glutathione in Complex I-Mediated Bioenergetic Failure in Brain Ischemia\/Reperfusion Injury","volume":"49","author":"Kahl","year":"2018","journal-title":"Stroke"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12934-020-01302-7","article-title":"Production of riboflavin and related cofactors by biotechnological processes","volume":"19","author":"Liu","year":"2020","journal-title":"Microb. Cell Factories"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0010-406X(62)90123-8","article-title":"Hydrolysis of flavin mononucleotide by acid phosphatases from animal tissues","volume":"5","author":"McCormick","year":"1962","journal-title":"Comp. Biochem. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/SLA.0000000000003513","article-title":"Novel Real-time Prediction of Liver Graft Function during Hypothermic Oxygenated Machine Perfusion before Liver Transplantation","volume":"270","author":"Muller","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12974-018-1282-6","article-title":"Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia\/reperfusion injury","volume":"15","author":"Gong","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/cr.2011.20","article-title":"Mitochondrial ROS fuel the inflammasome","volume":"21","author":"Sorbara","year":"2011","journal-title":"Cell Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Parente, A., Flores Carvalho, M., Eden, J., Dutkowski, P., and Schlegel, A. (2022). Mitochondria and Cancer Recurrence after Liver Transplantation-What Is the Benefit of Machine Perfusion?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179747"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/cr.2009.69","article-title":"Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis","volume":"19","author":"Lu","year":"2009","journal-title":"Cell Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41416-020-01125-8","article-title":"Roles of mitochondria in the hallmarks of metastasis","volume":"124","author":"Scheid","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.celrep.2014.06.043","article-title":"A mitochondrial switch promotes tumor metastasis","volume":"8","author":"Porporato","year":"2014","journal-title":"Cell Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/j.jhep.2023.10.033","article-title":"Current evidence on the beneficial HOPE-effect based on systematic reviews and meta-analyses in liver transplantation","volume":"80","author":"Parente","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kim, D.G., Hwang, S., Lee, K.W., Kim, J.M., You, Y.K., Choi, D., Ryu, J.H., Kim, B.W., Kim, D.S., and Cho, J.Y. (2024). Small graft size and hepatocellular carcinoma outcomes in living donor liver transplantation: A retrospective multicentric cohort study. Int. J. Surg.","DOI":"10.1097\/JS9.0000000000001532"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/lt.24868","article-title":"Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria","volume":"24","author":"Lee","year":"2018","journal-title":"Liver Transpl."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jcp.21172","article-title":"Liver regeneration","volume":"213","author":"Michalopoulos","year":"2007","journal-title":"J. Cell Physiol."},{"key":"ref_60","unstructured":"Kalra, A., Yetiskul, E., Wehrle, C.J., and Tuma, F. (2024). Physiology, Liver. StatPearls, StatPearls Publishing."},{"key":"ref_61","unstructured":"Vernon, H., Wehrle, C., and Kasi, A. (2020). Anatomy, Abdomen and Pelvis: Liver, StatPearls Publishing."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100846","DOI":"10.1016\/j.jhepr.2023.100846","article-title":"The role of ischemia-reperfusion injury and liver regeneration in hepatic tumor recurrence","volume":"5","author":"Maspero","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/hep.1840210531","article-title":"Rapid activation of the Stat3 transcription complex in liver regeneration","volume":"21","author":"Cressman","year":"1995","journal-title":"Hepatology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0006-291X(92)90844-B","article-title":"Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs","volume":"186","author":"Kono","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jss.2006.07.027","article-title":"VEGF is important for early liver regeneration after partial hepatectomy","volume":"138","author":"Bockhorn","year":"2007","journal-title":"J. Surg. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/abbs\/gms084","article-title":"Intersection of Hippo\/YAP and Wnt\/\u03b2-catenin signaling pathways","volume":"45","author":"Konsavage","year":"2013","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1478-3231.2011.02646.x","article-title":"Deregulation of Hippo kinase signalling in human hepatic malignancies","volume":"32","author":"Li","year":"2012","journal-title":"Liver Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/TP.0000000000002968","article-title":"Too Much, Too Little, or Just Right? The Importance of Allograft Portal Flow in Deceased Donor Liver Transplantation","volume":"104","author":"Matsushima","year":"2020","journal-title":"Transplantation"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Parente, A., Flores Carvalho, M., and Schlegel, A. (2023). Endothelial Cells and Mitochondria: Two Key Players in Liver Transplantation. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210091"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ajt.2024.02.023","article-title":"Biliary complications after adult-to-adult living-donor liver transplantation: An international multicenter study of 3633 cases","volume":"24","author":"Li","year":"2024","journal-title":"Am. J. Transplant."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s13046-019-1480-9","article-title":"Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis","volume":"38","author":"Yang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Gr\u0105t, M., Krawczyk, M., Wronka, K.M., Stypu\u0142kowski, J., Lewandowski, Z., Wasilewicz, M., Krawczyk, P., Gr\u0105t, K., Patkowski, W., and Zieniewicz, K. (2018). Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-27319-y"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.18632\/oncotarget.3355","article-title":"FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Yang, Y., and Zhang, X. (2023). An overview of extrahepatic cholangiocarcinoma: From here to where?. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1171098"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41586-018-0519-y","article-title":"Necroptosis microenvironment directs lineage commitment in liver cancer","volume":"562","author":"Seehawer","year":"2018","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Sarcognato, S., Jong, I.E.M., Fabris, L., Cadamuro, M., and Guido, M. (2020). Necroptosis in Cholangiocarcinoma. Cells, 9.","DOI":"10.3390\/cells9040982"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.6002\/ect.2021.0457","article-title":"Tumor Microenvironment: Necroptosis Switches the Subtype of Liver Cancer While Necrosis Promotes Tumor Recurrence and Progression","volume":"21","year":"2023","journal-title":"Exp. Clin. Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.7314\/APJCP.2014.15.14.5873","article-title":"High expression of HIF-1\u03b1, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis","volume":"15","author":"Thongchot","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Sharma, A., Sinha, S., and Shrivastava, N. (2022). Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.849040"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.hpb.2019.12.002","article-title":"Effect of remote ischemic preConditioning on liver injury in patients undergoing liver resection: The ERIC-LIVER trial","volume":"22","author":"Teo","year":"2020","journal-title":"HPB"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-016-1408-1","article-title":"Hypoxia-inducible factors as molecular targets for liver diseases","volume":"94","author":"Ju","year":"2016","journal-title":"J. Mol. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/tgh.2019.10.12","article-title":"Nonalcoholic steatohepatitis recurrence after liver transplant","volume":"5","author":"Taneja","year":"2020","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_85","first-page":"293","article-title":"Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment","volume":"14","author":"Tabibian","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e0179","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: Epidemiology, prognosis, and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jgh.15329","article-title":"Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta-analysis","volume":"36","author":"Lv","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_88","first-page":"304","article-title":"Recurrence of hepatitis C after liver transplantation","volume":"26","author":"Vinaixa","year":"2013","journal-title":"Ann. Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4292\/wjgpt.v3.i4.36","article-title":"Prevention of hepatitis C recurrence after liver transplantation: An update","volume":"3","author":"Carbone","year":"2012","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jhep.2004.04.023","article-title":"Prevention and treatment of hepatitis C virus recurrence after liver transplantation","volume":"41","author":"Forns","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"101938","DOI":"10.1016\/j.eclinm.2023.101938","article-title":"Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: Systematic review and meta-analysis","volume":"58","author":"Olaru","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"100599","DOI":"10.1016\/j.jhepr.2022.100599","article-title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study","volume":"4","author":"Visseren","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"11729","DOI":"10.3389\/ti.2023.11729","article-title":"Liver Transplantation for Primary Sclerosing Cholangitis (PSC) with or without Inflammatory Bowel Disease (IBD)\u2014A European Society of Organ Transplantation (ESOT) Consensus Statement","volume":"36","author":"Carbone","year":"2023","journal-title":"Transpl. Int."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.14828","article-title":"The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis","volume":"48","author":"Trivedi","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/SLA.0000000000006041","article-title":"Ileal Pouch-anal Anastomosis in Primary Sclerosing Cholangitis-inflammatory Bowel Disease (PSC-IBD): Long-term Pouch and Liver Transplant Outcomes","volume":"278","author":"Maspero","year":"2023","journal-title":"Ann. Surg."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Catanzaro, E., Gringeri, E., Cazzagon, N., Floreani, A., Cillo, U., Burra, P., and Gambato, M. (2024). Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. J. Pers. Med., 14.","DOI":"10.3390\/jpm14030222"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/lt.24496","article-title":"Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients","volume":"22","author":"Gordon","year":"2016","journal-title":"Liver Transpl."},{"key":"ref_100","first-page":"335","article-title":"Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis","volume":"177","author":"Malinchoc","year":"1993","journal-title":"Surg. Gynecol. Obstet."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/TP.0000000000003595","article-title":"How to Preserve Liver Grafts from Circulatory Death with Long Warm Ischemia? A Retrospective Italian Cohort Study with Normothermic Regional Perfusion and Hypothermic Oxygenated Perfusion","volume":"105","author":"Schlegel","year":"2021","journal-title":"Transplantation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.hpb.2019.01.004","article-title":"Can hypothermic oxygenated perfusion (HOPE) rescue futile DCD liver grafts?","volume":"21","author":"Muller","year":"2019","journal-title":"HPB"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"785","DOI":"10.21037\/hbsn-23-180","article-title":"The conclusion of reducing acute rejection after liver transplantation by machine perfusion should be extrapolated with caution","volume":"12","author":"Liang","year":"2023","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ronca, V., Wootton, G., Milani, C., and Cain, O. (2020). The Immunological Basis of Liver Allograft Rejection. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02155"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent Primary Biliary Cirrhosis After Liver Transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors Associated with Recurrence of Primary Biliary Cholangitis after Liver Transplantation and Effects on Graft and Patient Survival","volume":"156","author":"Hansen","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3348\/kjr.2023.0832","article-title":"Post-COVID-19 Cholangiopathy: Clinical and Radiologic Findings","volume":"24","author":"Kim","year":"2023","journal-title":"Korean J. Radiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2022.01.022","article-title":"Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation","volume":"77","author":"Ronca","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/13651820801992542","article-title":"Surgery for cholangiocarcinoma: The role of liver transplantation","volume":"10","author":"Rosen","year":"2008","journal-title":"HPB"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"zrad025","DOI":"10.1093\/bjsopen\/zrad025","article-title":"Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: Multicentre, retrospective cohort study","volume":"7","author":"Hoogwater","year":"2023","journal-title":"BJS Open"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: A prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.2147\/JIR.S460103","article-title":"The Clinical Association between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma after R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis","volume":"17","author":"Huang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jhep.2023.05.027","article-title":"Machine perfusion techniques for liver transplantation\u2014A meta-analysis of the first seven randomized-controlled trials","volume":"79","author":"Parente","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jhep.2018.10.005","article-title":"Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation","volume":"70","author":"Schlegel","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOT.0000000000001015","article-title":"Mitochondria and ischemia reperfusion injury","volume":"27","author":"Panconesi","year":"2022","journal-title":"Curr. Opin. Organ Transplant."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jhep.2022.12.030","article-title":"A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation","volume":"78","author":"Schlegel","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"154361","DOI":"10.1016\/j.prp.2023.154361","article-title":"Predictive value of portal fibrosis and inflammation in transplanted liver grafts treated with hypothermic oxygenated perfusion","volume":"243","author":"Vasuri","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/ajt.16996","article-title":"Outcome of liver transplantation with grafts from brain-dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors","volume":"22","author":"Patrono","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.1038\/s41467-023-43368-y","article-title":"Bile proteome reveals biliary regeneration during normothermic preservation of human donor livers","volume":"14","author":"Thorne","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Patrono, D., Colli, F., Colangelo, M., De Stefano, N., Apostu, A.L., Mazza, E., Catalano, S., Rizza, G., Mirabella, S., and Romagnoli, R. (2023). How Can Machine Perfusion Change the Paradigm of Liver Transplantation for Patients with Perihilar Cholangiocarcinoma?. J. Clin. Med., 12.","DOI":"10.3390\/jcm12052026"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2020.12.005","article-title":"Risk factors for recurrent primary biliary cirrhosis after liver transplantation: A systematic review and meta-analysis","volume":"53","author":"Li","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e16123","DOI":"10.1200\/JCO.2022.40.16_suppl.e16123","article-title":"Feasibility of disease recurrence monitoring in liver post-transplantation for patients with hepatocellular carcinoma via personalized and tumor-informed ctDNA test","volume":"40","author":"Abdelrahim","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Chen, H., Lu, D., Yang, X., Hu, Z., He, C., Li, H., Lin, Z., Yang, M., and Xu, X. (2022). One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia\/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.879552"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/TP.0000000000004597","article-title":"N-acetylcysteine in the Donor, Recipient, or Both Donor and Recipient in Liver Transplantation: A Systematic Review with Meta-analysis and Trial Sequential Analysis","volume":"107","author":"Jia","year":"2023","journal-title":"Transplantation"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2020.04.040","article-title":"UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice","volume":"73","author":"Dyson","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S2468-1253(23)00335-7","article-title":"Direct-acting antiviral therapies for hepatitis C infection: Global registration, reimbursement, and restrictions","volume":"9","author":"Marshall","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e240302","DOI":"10.1001\/jamahealthforum.2024.0302","article-title":"Changes in Use of Hepatitis C Direct-Acting Antivirals After Access Restrictions Were Eased by State Medicaid Programs","volume":"5","author":"Davey","year":"2024","journal-title":"JAMA Health Forum."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.15253","article-title":"Systematic review with meta-analysis: Sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma","volume":"49","author":"Grigg","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Fares, S., Wehrle, C.J., Hong, H., Sun, K., Jiao, C., Zhang, M., Gross, A., Allkushi, E., Uysal, M., and Kamath, S. (2024). Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma. Cancers, 16.","DOI":"10.3390\/cancers16081453"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Wehrle, C.J., Hong, H., Kamath, S., Schlegel, A., Fujiki, M., Hashimoto, K., Kwon, D.C.H., Miller, C., Walsh, R.M., and Aucejo, F. (2024). Tumor Mutational Burden from Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma after Resection: An Emerging Biomarker for Surveillance: An Emerging Biomarker for Surveillance. Ann. Surg.","DOI":"10.1097\/SLA.0000000000006386"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s11605-023-05723-8","article-title":"Liquid Biopsy by ctDNA in Liver Transplantation for Colorectal Cancer Liver Metastasis","volume":"27","author":"Wehrle","year":"2023","journal-title":"J. Gastrointest. Surg."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e2300111","DOI":"10.1200\/CCI.23.00111","article-title":"Circulating Tumor DNA in Colorectal Cancer Liver Metastasis: Analysis of Patients Receiving Liver Resection and Transplant","volume":"7","author":"Wehrle","year":"2023","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Hong, H., Wehrle, C.J., Zhang, M., Fares, S., Stitzel, H., Garib, D., Estfan, B., Kamath, S., Krishnamurthi, S., and Ma, W.W. (2024). Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept. Cancers, 16.","DOI":"10.3390\/cancers16050927"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/tri.13692","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant\u2014A pilot study","volume":"33","author":"Visseren","year":"2020","journal-title":"Transpl. Int."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.cgh.2023.04.004","article-title":"Recent Advances in the Management of Primary Sclerosing Cholangitis","volume":"21","author":"Assis","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajt.16835","article-title":"Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients","volume":"22","author":"Levitsky","year":"2022","journal-title":"Am. J. Transplant."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/16\/2789\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:31:45Z","timestamp":1760110305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/16\/2789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":138,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["cancers16162789"],"URL":"https:\/\/doi.org\/10.3390\/cancers16162789","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]}}}